Loading
Natural Health Trends Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by BROADY GEORGE K, was filed 24 Jun 2019.
Natural Health Trends Corp: what insiders have been doing
This page follows insider dealings at Natural Health Trends Corp as filed with SEC (Form 4), a company from the Healthcare & Pharma sector. Nothing new has been filed by managers of Natural Health Trends Corp in twelve months, the latest record being from 16 December 2024.
The full history, which starts in 2016, counts 1 purchase against 25 sales. The 10-K for the year ended 31 December 2025 shows 39.8 m USD of revenue and -882,000 USD of net income and a dividend of 0.80 USD per share.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
215
Thresholds
n/a
Buy Volume
€14,377
1 ops. · all time
Sell Volume
€10M
25 ops. · all time
Since the insiders bought
- -27.6%Entry US$7.87 · Close at T+365 US$5.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,540 of 26,289 companies
25.9
score / 100
Value8
Quality43
FCF yld-75%
Earn yld-11%
EV/EBITDA·
ROE-7.4%
Gross mgn74%
Net mgn-2.2%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.95
Analyst consensus
Income statement
RevenueUS$39.8M
Gross profitUS$29.3M74% margin
EBITDA-US$1.7M-4% margin
Net income-US$882k-4.5% margin
Valuation
P/Book0.5x
Beta1.00
Balance sheet & cash
Market capUS$8.1M
Total debtUS$2M
Free Cash Flow-US$6.1M
Debt / Equity18%
Profitability & ownership
ROE-7.4%
ROA-3.8%
% insiders12.9%
% institutions12.2%
Last declaration on 16 December 2024
Declarations215 total
1,298 shares@ US$4.265.2% of flowCommon StockSEC:0001437749-24-037642:1
1,298 shares@ US$4.265.2% of flowCommon StockSEC:0001437749-24-037640:1
1,664 shares@ US$4.265.2% of flowCommon StockSEC:0001437749-24-037644:1
5,220 shares@ US$4.261.5% of flowCommon StockSEC:0001437749-24-037635:1
15,608 shares@ US$4.261.7% of flowCommon StockSEC:0001437749-24-037637:1
1,664 sharesCommon StockSEC:0001437749-24-037644:0
15,608 sharesCommon StockSEC:0001437749-24-037637:0
1,298 sharesCommon StockSEC:0001437749-24-037640:0
1,298 sharesCommon StockSEC:0001437749-24-037642:0
5,220 sharesCommon StockSEC:0001437749-24-037635:0
1,296 shares@ US$6.807.8% of flowCommon StockSEC:0001437749-24-029300:1
15,606 shares@ US$6.802.5% of flowCommon StockSEC:0001437749-24-029295:1
1,667 shares@ US$6.807.8% of flowCommon StockSEC:0001437749-24-029303:1
5,224 shares@ US$6.802.3% of flowCommon StockSEC:0001437749-24-029292:1
1,296 shares@ US$6.807.8% of flowCommon StockSEC:0001437749-24-029298:1
1,667 sharesCommon StockSEC:0001437749-24-029303:0
15,606 sharesCommon StockSEC:0001437749-24-029295:0
1,296 sharesCommon StockSEC:0001437749-24-029300:0
5,224 sharesCommon StockSEC:0001437749-24-029292:0
1,296 sharesCommon StockSEC:0001437749-24-029298:0
1,296 shares@ US$6.808.0% of flowCommon StockSEC:0001437749-24-020555:1
15,606 shares@ US$6.802.6% of flowCommon StockSEC:0001437749-24-020551:1
1,667 shares@ US$6.808.0% of flowCommon StockSEC:0001437749-24-020553:1
5,224 shares@ US$6.802.4% of flowCommon StockSEC:0001437749-24-020549:1
1,296 shares@ US$6.808.0% of flowCommon StockSEC:0001437749-24-020557:1
25 of 215 declarations
About Natural Health Trends Corp
Natural Health Trends Corp. (NASDAQ: NHTC) is a U.S.-listed company traded on the NASDAQ market in the United States. It operates as an international direct-selling and e-commerce business focused on premium personal care, wellness, and broader “quality of life” products marketed under the NHT Global brand. For investors, NHTC is a niche consumer-health distribution story rather than a traditional pharmaceutical company, with performance driven more by member engagement, product cycles, promotional execution, and channel economics than by patent portfolios or large-scale R&D.
The company was incorporated in Delaware and has built its business through subsidiaries selling into multiple regions. A notable corporate milestone came in February 2025, when Natural Health Trends relocated its headquarters from Hong Kong to Rolling Hills Estates, California. That move strengthens the company’s U.S. corporate footprint and is relevant for investors assessing governance, disclosure, and proximity to U.S. capital markets. At the same time, the operating footprint remains international, with activity across Asia, the Americas, and Europe.
Read moreShow less
NHTC’s core business model is straightforward but highly execution-sensitive: products are sold through a direct-selling network and online channels, with independent members/distributors placing orders and promoting the brand. The main product categories are personal care, wellness, and lifestyle-related products. This concentration gives the company a relatively clear brand identity, but it also means the business is exposed to demand softness, distributor attrition, and regional concentration risk, particularly in Asia where the company has historically generated a significant share of activity.
From a competitive standpoint, Natural Health Trends operates in a crowded direct-selling and wellness marketplace where brand credibility, product repeat purchase rates, logistics, and channel incentives matter. The company’s market position appears specialized rather than dominant: it is best viewed as a smaller-scale international direct seller with a focused product portfolio and a geographically diversified, though uneven, revenue base. Its advantage lies in the established NHT Global brand and its cross-border sales infrastructure; its limitations are the modest scale and the inherent volatility of a member-driven model.
Recent developments are important for investors. In 2025 and 2026, the company reported weaker top-line trends in certain periods and a decline in active members versus prior-year levels, signaling ongoing pressure in the sales network. Management also highlighted restructuring initiatives expected to generate annualized savings, while maintaining a quarterly cash dividend. In its 2026 commentary, the company said it had relocated about 40% of its product sourcing base from the Americas to East Asia to reduce tariff uncertainty and streamline logistics. That type of supply-chain repositioning suggests management is actively adjusting the operating model to improve resilience and cost efficiency.
Overall, NHTC remains a small-cap NASDAQ consumer-health name with an international footprint, a lean product set, and a business model that is highly sensitive to distributor momentum, regional demand, and execution discipline.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
